Jump Financial’s Novavax NVAX Stock Holding History

Jump Financial’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Buy	204,815 +183,515	+862%	+$1.64M	0.02%	920
2026 Q1	$173K	Sell	21,300 -445,802	-95%	-$4.04M	﹤0.01%	1691
2025 Q4	$3.14M	Buy	467,102 +20,302	+5%	+$153K	0.04%	516
2025 Q3	$3.87M	Buy	+446,800	New	+$3.48M	0.05%	497
2025 Q2	–	Sell	-511,742	Closed	-$3.28M	–	2045
2025 Q1	$3.28M	Buy	+511,742	New	+$4.23M	0.04%	438
2024 Q4	–	Sell	-598,018	Closed	-$7.55M	–	1888
2024 Q3	$7.55M	Buy	+598,018	New	+$7.72M	0.15%	139
2023 Q4	–	Sell	-302,473	Closed	-$2.19M	–	2091
2023 Q3	$2.19M	Buy	302,473 +61,274	+25%	+$490K	0.08%	339
2023 Q2	$1.79M	Sell	241,199 -169,715	-41%	-$1.33M	0.07%	435
2023 Q1	$2.85M	Buy	+410,914	New	+$3.78M	0.12%	276
2022 Q3	–	Sell	-75,356	Closed	-$3.88M	–	1836
2022 Q2	$3.88M	Buy	+75,356	New	+$3.9M	0.17%	165
2022 Q1	–	Sell	-1,700	Closed	-$243K	–	1793
2021 Q4	$243K	Buy	+1,700	New	+$292K	0.02%	1007
2020 Q4	–	Sell	-10,372	Closed	-$1.12M	–	1109
2020 Q3	$1.12M	Buy	+10,372	New	+$1.26M	0.23%	93

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Jump Financial's NVAX Position: Q2 2026 in Review

Jump Financial increased its Novavax (NVAX) stake by 862% in Q2 2026, buying an estimated $1.64M and bringing the position to 204,815 shares worth $1.93M. The position accounts for 0.02% of the portfolio, ranked #920.

Jump Financial first reported a position in NVAX in Q3 2020 and has held it in 12 quarters since. The position peaked at $7.55M in Q3 2024. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Jump Financial held 204,815 shares of Novavax worth $1.93M as of Q2 2026.
Jump Financial bought 183,515 Novavax shares in Q2 2026, an estimated $1.64M.
Novavax made up 0.02% of Jump Financial's portfolio in Q2 2026, its #920 holding.
Jump Financial first reported a position in Novavax in Q3 2020 and has held it in 12 quarters since.
Jump Financial's Novavax position peaked at $7.55M in Q3 2024.
266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.